Trial Profile

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Feb 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SPARC-1613 (Primary)
Indications Advanced breast cancer; Male breast cancer
Focus Pharmacokinetics
Sponsors Sun Pharma Advanced Research Company

Most Recent Events

25 Feb 2019 Status changed from active, no longer recruiting to completed.
09 Dec 2018 Status changed from recruiting to active, no longer recruiting.
06 Jun 2018 Planned End Date changed from 30 Jun 2018 to 28 Feb 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com